Publications by authors named "M Samuel Collin"

Claim this Profile
M
Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment.
Mélanie Debiais, Anthony Tarabay, Sarah Blanchet-Deverly, Géraldine M Camilleri, Alexandre Megherbi, Maxime Collin

Eur J Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation.
Maymoon M Madkhali, Alex Mitchell, Callum Wright, Kim Pearce, Srishty Aku, Matthew Collin

Br J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.
Iman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire, Jaime Sanz, Anne Huynh, Matthew Collin

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1 cDC1 infiltration and activates anti-tumor immunity.
Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely, Jérémie Bornères, Nathan Vaudiau, Matthieu Collin

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study.
Leher Gumber, Reza Omidvar, Francesca Gonnelli, Adam Taylor, Thomas Trimble, Matthew Collin

Lancet Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis